ROACCUTANE isotretinoin 20mg capsule Australia - engelsk - Department of Health (Therapeutic Goods Administration)

roaccutane isotretinoin 20mg capsule

roche products pty ltd - isotretinoin, quantity: 20 mg - capsule, soft - excipient ingredients: yellow beeswax; hydrogenated soya oil; soya oil; gelatin; glycerol; titanium dioxide; partially hydrogenated soya oil; iron oxide red; maize starch; sorbitol; mannitol; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - roaccutane is indicated for the treatment of severe cystic acne, and a single course of therapy has been shown to result in complete and prolonged remission of disease in many patients. if a second course of therapy is needed, it should not be initiated until at least eight weeks after completion of the first course, since experience has shown that patients may continue to improve while off drug. because of significant adverse effects associated with its use, roaccutane should be reserved for patients with severe cystic acne who are unresponsive to conventional therapy, including systemic antibiotics.

ROACCUTANE 10 mg Romania - rumensk - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

roaccutane 10 mg

roche pharma ag - germania - isotretinoinum - caps. moi - 10mg - preparate de uz sistemic pt. trat. acneei retinoizi pentru tratamentul acneei

Roaccutane Litauen - litauisk - SMCA (Valstybinė vaistų kontrolės tarnyba)

roaccutane

roche lietuva, uab - izotretinoinas - minkštosios kapsulės - 20 mg; 10 mg - isotretinoin